68ga-exendin
PeptideexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 6, 2014 (NCT02127541)
Timeline
No events for the selected filters.
Mechanism of action
EHMT1 binding agent
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 68-Gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-exendin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05662189 | N/A | Mar 15, 2022 | University of Parma |
| NCT02127541 | N/A | Jan 6, 2014 | University of Basel, University of Bern |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Basel | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Bern | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Parma | Academic/Hospital | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1